Quick answers
- What is Gaviscon?
- Gaviscon is a brand name of Aluminum hydroxide and magnesium carbonate, an over-the-counter medicine. The FDA NDC Directory lists 5 Gaviscon products in 3 strengths and forms.
- Who makes Gaviscon?
- Haleon US Holdings LLC lists 5 of the 5 Gaviscon products in the FDA NDC Directory.
- Is there a generic or store brand of Gaviscon?
- Yes. The FDA NDC Directory lists 23 other products with the same active ingredients, strength and form as a Gaviscon product, 23 of them generic or store brands. Ask your pharmacist whether one is right for you.
- Has Gaviscon been recalled?
- FDA enforcement reports list 4 recalls of Gaviscon products; the newest started May 28, 2020. A recall usually concerns specific lots, not every product.
What Gaviscon is
Each Gaviscon product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Aluminum hydroxide and magnesium carbonate · over-the-counter medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| aluminum hydroxide 160 mg · magnesium carbonate 105 mg tablet, chewable (oral) | Gaviscon Extra Strength | 18 products, 14 companies | DailyMed |
| aluminum hydroxide 254 mg/5 mL · magnesium carbonate 237.5 mg/5 mL liquid (oral) | Gaviscon | 4 products, 4 companies | DailyMed |
| aluminum hydroxide 95 mg/15 mL · magnesium carbonate 358 mg/15 mL liquid (oral) | Gaviscon | 1 product, 1 company | DailyMed |
Its page quotes the Drug Facts label and lists every brand and store brand: Aluminum hydroxide and magnesium carbonate →
FDA approval
Gaviscon products are sold under an FDA over-the-counter monograph: rules that set the allowed active ingredients, strengths and label wording, so these products do not need an individual FDA approval.
Companies that list Gaviscon
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Gaviscon products.
- Haleon US Holdings LLC5 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
May 28, 2020 · Class II · Terminated · D-1324-2020
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41 — Glaxosmithkline Consumer Healthcare Holdings
-
May 28, 2020 · Class II · Terminated · D-1322-2020
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Gaviscon Regular Strength Liquid Antacid Cool Mint, 6 FL OZ (177 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-42 — Glaxosmithkline Consumer Healthcare Holdings
-
May 28, 2020 · Class II · Terminated · D-1323-2020
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-41 — Glaxosmithkline Consumer Healthcare Holdings
-
May 28, 2020 · Class II · Terminated · D-1325-2020
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Gaviscon Liquid Antacid Extra Strength, Cool Mint, 12 FL OZ (355 mL) single pack and twin pack, Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0095-41 — Glaxosmithkline Consumer Healthcare Holdings
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.